226 related articles for article (PubMed ID: 34608677)
1. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.
Lee A; Nahm CH; Lee JS; Lee MK; Lee KR
J Clin Lab Anal; 2021 Nov; 35(11):e24004. PubMed ID: 34608677
[TBL] [Abstract][Full Text] [Related]
2. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
Cherubini F; Cristiano A; Valentini A; Bernardini S; Nuccetelli M
Inflamm Res; 2021 Jun; 70(6):687-694. PubMed ID: 33956194
[TBL] [Abstract][Full Text] [Related]
3. Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome.
Hoy CK; NaveenKumar SK; Navaz SA; Sugur K; Yalavarthi S; Sarosh C; Smith T; Kmetova K; Chong E; Peters NF; Rysenga CE; Norman GL; Figueroa-Parra G; Nelson D; Girard J; Ahmed AZ; Schaefer JK; Gudjonsson JE; Kahlenberg JM; Madison JA; Knight JS; Crowson CS; Duarte-García A; Zuo Y
Arthritis Rheumatol; 2024 Jun; 76(6):928-935. PubMed ID: 38225923
[TBL] [Abstract][Full Text] [Related]
4. Serum calprotectin as a novel biomarker for severity of COVID-19 disease.
Kaya T; Yaylacı S; Nalbant A; Yıldırım İ; Kocayiğit H; Çokluk E; Şekeroğlu MR; Köroğlu M; Güçlü E
Ir J Med Sci; 2022 Feb; 191(1):59-64. PubMed ID: 33641087
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.
Trahtemberg U; Rottapel R; Dos Santos CC; Slutsky AS; Baker A; Fritzler MJ
Ann Rheum Dis; 2021 Sep; 80(9):1236-1240. PubMed ID: 33903092
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.
Taha M; Samavati L
RMD Open; 2021 May; 7(2):. PubMed ID: 33958439
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.
Shi H; Zuo Y; Yalavarthi S; Gockman K; Zuo M; Madison JA; Blair C; Woodward W; Lezak SP; Lugogo NL; Woods RJ; Lood C; Knight JS; Kanthi Y
J Leukoc Biol; 2021 Jan; 109(1):67-72. PubMed ID: 32869342
[TBL] [Abstract][Full Text] [Related]
8. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
Hurnakova J; Hulejova H; Zavada J; Komarc M; Cerezo LA; Mann H; Vencovsky J; Pavelka K; Senolt L
Clin Rheumatol; 2018 Aug; 37(8):2055-2062. PubMed ID: 29656372
[TBL] [Abstract][Full Text] [Related]
11. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
12. Serum calprotectin can indicate current and future severity of COVID-19.
Shokri-Afra H; Moradi M; Musavi H; Moradi-Sardareh H; Moradi Poodeh B; Kazemi Veisari A; Oladi Z; Ebrahimi M
J Clin Lab Anal; 2023 Jan; 37(1):e24809. PubMed ID: 36525302
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).
García de Guadiana-Romualdo L; Rodríguez Rojas C; Morell-García D; Andaluz-Ojeda D; Rodríguez Mulero MD; Rodríguez-Borja E; Ballesteros-Vizoso A; Calvo MD; Albert-Botella L; Pozo Giráldez A; Llompart-Alabern I; Bolado Jiménez C; Hernández Olivo M; Fernández Presa L; Ortega-Pérez J; Fora Romero MJ; Campos-Rodríguez V; Ballester Férriz A; Guiu-Martí AM; Pinilla Arribas L; Galindo Martínez M; Puerto-Lara ER; López Tarazaga AB; Ros Braquehais MS; Nogales Martín L; Juez Santamaría C; Trapiello Fernández W; Espinilla Fernández V; Havelka A; Albaladejo-Otón MD
Inflamm Res; 2022 Jan; 71(1):57-67. PubMed ID: 34718856
[TBL] [Abstract][Full Text] [Related]
14. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
[TBL] [Abstract][Full Text] [Related]
15. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
16. Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19.
Bertin D; Brodovitch A; Lopez A; Arcani R; Thomas GM; Beziane A; Weber S; Babacci B; Heim X; Rey L; Leone M; Mege JL; Bardin N
Sci Rep; 2022 Jul; 12(1):12523. PubMed ID: 35869087
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
18. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
[TBL] [Abstract][Full Text] [Related]
19. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2008 Apr; 59(4):561-7. PubMed ID: 18383424
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit.
Hamadé A; Woehl B; Harzallah I; Talbot M; Tousch J; Jambert L
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):73-79. PubMed ID: 33273262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
